Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Presence of a peptide component of thymosin fraction-5 manifesting discrete cytostatic properties in HL-60 human promyelocytic leukemia cells.

Spangelo BL, Pompilius M, Farrimond DD, Stevens N, Nieva R, Shroff S, Badamchian M, Johnson CR, Jarvis WD.

Int Immunopharmacol. 2005 Jul;5(7-8):1317-29.

PMID:
15914336
2.

Somatostatin and gamma-aminobutyric acid inhibit interleukin-1 beta-stimulated release of interleukin-6 from rat C6 glioma cells.

Spangelo BL, Horrell S, Goodwin AL, Shroff S, Jarvis WD.

Neuroimmunomodulation. 2004;11(5):332-40.

PMID:
15316244
3.

Caspase-9 regulation: an update.

Johnson CR, Jarvis WD.

Apoptosis. 2004 Jul;9(4):423-7. Review.

PMID:
15192324
4.

Intrinsic cytotoxicity and chemomodulatory actions of novel phenethylisothiocyanate sphingoid base derivatives in HL-60 human promyelocytic leukemia cells.

Johnson CR, Chun J, Bittman R, Jarvis WD.

J Pharmacol Exp Ther. 2004 May;309(2):452-61. Epub 2004 Jan 14.

PMID:
14724218
5.

Specific inhibition of Stat5a/b promotes apoptosis of IL-2-responsive primary and tumor-derived lymphoid cells.

Behbod F, Nagy ZS, Stepkowski SM, Karras J, Johnson CR, Jarvis WD, Kirken RA.

J Immunol. 2003 Oct 15;171(8):3919-27.

6.

Requirement for SAPK-JNK signaling in the induction of apoptosis by ribosomal stress in REH lymphoid leukemia cells.

Johnson CR, Jiffar T, Fischer UM, Ruvolo PP, Jarvis WD.

Leukemia. 2003 Nov;17(11):2140-8.

PMID:
12970763
7.

Protein kinase C targeting in antineoplastic treatment strategies.

Jarvis WD, Grant S.

Invest New Drugs. 1999;17(3):227-40. Review.

PMID:
10665476
8.
9.

Follicular dendritic cells protect malignant B cells from apoptosis induced by anti-Fas and antineoplastic agents.

Schwarz YX, Yang My, Qin D, Wu J, Jarvis WD, Grant S, Burton GF, Szakal AK, Tew JG.

J Immunol. 1999 Dec 15;163(12):6442-7.

10.

Downregulation of delta CaM kinase II in human tumor cells.

Tombes RM, Mikkelsen RB, Jarvis WD, Grant S.

Biochim Biophys Acta. 1999 Oct 13;1452(1):1-11.

11.

Evidence that the apoptotic actions of etoposide are independent of c-Jun/activating protein-1-mediated transregulation.

Jarvis WD, Johnson CR, Fornari FA, Park JS, Dent P, Grant S.

J Pharmacol Exp Ther. 1999 Sep;290(3):1384-92.

PMID:
10454518
13.

The role of ceramide in the cellular response to cytotoxic agents.

Jarvis WD, Grant S.

Curr Opin Oncol. 1998 Nov;10(6):552-9. Review.

PMID:
9818235
14.
16.

Role of sphingolipid-mediated cell death in neurodegenerative diseases.

Ariga T, Jarvis WD, Yu RK.

J Lipid Res. 1998 Jan;39(1):1-16. Review.

17.

Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine.

Jarvis WD, Fornari FA Jr, Auer KL, Freemerman AJ, Szabo E, Birrer MJ, Johnson CR, Barbour SE, Dent P, Grant S.

Mol Pharmacol. 1997 Dec;52(6):935-47.

PMID:
9415703
18.

Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2.

Wang S, Vrana JA, Bartimole TM, Freemerman AJ, Jarvis WD, Kramer LB, Krystal G, Dent P, Grant S.

Mol Pharmacol. 1997 Dec;52(6):1000-9.

PMID:
9396780
19.
20.

Positive and negative regulation of JNK1 by protein kinase C and p42(MAP kinase) in adult rat hepatocytes.

Jarvis WD, Auer KL, Spector M, Kunos G, Grant S, Hylemon P, Mikkelsen R, Dent P.

FEBS Lett. 1997 Jul 21;412(1):9-14.

21.
22.
23.
24.
25.

Lysophosphatidylcholine stimulates interleukin-6 release from rat anterior pituitary cells in vitro.

Spangelo BL, Jarvis WD.

Endocrinology. 1996 Oct;137(10):4419-26.

PMID:
8828503
26.

Hepatocellular protein kinase C activation by bile acids: implications for regulation of cholesterol 7 alpha-hydroxylase.

Stravitz RT, Rao YP, Vlahcevic ZR, Gurley EC, Jarvis WD, Hylemon PB.

Am J Physiol. 1996 Aug;271(2 Pt 1):G293-303.

PMID:
8770045
27.

Effect of AS101 on bryostatin 1-mediated differentiation induction, cell cycle arrest, and modulation of drug-induced apoptosis in human myeloid leukemia cells.

Rao AS, Freemerman AJ, Jarvis WD, Chelliah J, Bear HD, Mikkelsen R, Grant S.

Leukemia. 1996 Jul;10(7):1150-8.

PMID:
8683995
28.

Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).

Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, Szabo E, Chelliah J, Jarvis WD.

Cell Growth Differ. 1996 May;7(5):603-13.

29.

Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells.

Jarvis WD, Fornari FA, Traylor RS, Martin HA, Kramer LB, Erukulla RK, Bittman R, Grant S.

J Biol Chem. 1996 Apr 5;271(14):8275-84.

30.

Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis.

Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN.

Nature. 1996 Mar 7;380(6569):75-9.

PMID:
8598911
31.

Radiosensitization of HL-60 human leukaemia cells by bryostatin-1 in the absence of increased DNA fragmentation or apoptotic cell death.

Watson NC, Jarvis WD, Orr MS, Grant S, Gewirtz DA.

Int J Radiat Biol. 1996 Feb;69(2):183-92.

PMID:
8609454
32.

Ceramide and the induction of apoptosis.

Jarvis WD, Grant S, Kolesnick RN.

Clin Cancer Res. 1996 Jan;2(1):1-6. Review. No abstract available.

33.

Induction of apoptotic DNA fragmentation and c-jun downregulation in human myeloid leukemia cells by the permeant Ca2+ chelator BAPTA/AM.

Grant S, Freemerman AJ, Gregory PC, Martin HA, Turner AJ, Mikkelsen R, Chelliah J, Yanovich S, Jarvis WD.

Oncol Res. 1995;7(7-8):381-92.

PMID:
8747601
34.

Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells.

Jarvis WD, Fornari FA Jr, Browning JL, Gewirtz DA, Kolesnick RN, Grant S.

J Biol Chem. 1994 Dec 16;269(50):31685-92.

35.
36.
37.

Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells.

Jarvis WD, Povirk LF, Turner AJ, Traylor RS, Gewirtz DA, Pettit GR, Grant S.

Biochem Pharmacol. 1994 Mar 2;47(5):839-52.

PMID:
8135859
38.

Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway.

Jarvis WD, Kolesnick RN, Fornari FA, Traylor RS, Gewirtz DA, Grant S.

Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):73-7.

40.

Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.

Grant S, Jarvis WD, Swerdlow PS, Turner AJ, Traylor RS, Wallace HJ, Lin PS, Pettit GR, Gewirtz DA.

Cancer Res. 1992 Nov 15;52(22):6270-8.

41.

Effects of bryostatin 1 and rGM-CSF on the metabolism of 1-beta-D-arabinofuranosylcytosine in human leukaemic myeloblasts.

Grant S, Jarvis WD, Turner AJ, Wallace HJ, Pettit GR.

Br J Haematol. 1992 Nov;82(3):522-8.

PMID:
1486032
42.
43.

Physiological and biochemical effects of bradykinin and lys-bradykinin in pituitary cells.

Kuan SI, Judd AM, Jarvis WD, Login IS, MacLeod RM.

Mol Cell Endocrinol. 1990 Sep 10;72(3):239-46.

PMID:
1963159
44.
45.

Evaluation of image quality in individual films of double film packets.

Jarvis WD, Pifer RG, Griffin JA, Skidmore AE.

Oral Surg Oral Med Oral Pathol. 1990 Jun;69(6):764-7.

PMID:
2356089
46.

Attenuation of anterior pituitary phosphoinositide phosphorylase activity by the D2 dopamine receptor.

Jarvis WD, Judd AM, MacLeod RM.

Endocrinology. 1988 Dec;123(6):2793-9.

PMID:
2904359
47.

Characterization of the MMQ cell, a prolactin-secreting clonal cell line that is responsive to dopamine.

Judd AM, Login IS, Kovacs K, Ross PC, Spangelo BL, Jarvis WD, MacLeod RM.

Endocrinology. 1988 Nov;123(5):2341-50.

PMID:
2844508
48.

Attenuation of pituitary polyphosphoinositide metabolism by protein kinase C activation.

Judd AM, Jarvis WD, MacLeod RM.

Mol Cell Endocrinol. 1987 Dec;54(2-3):107-14.

PMID:
2826275
49.

Thymosin fraction 5 stimulates prolactin and growth hormone release from anterior pituitary cells in vitro.

Spangelo BL, Judd AM, Ross PC, Login IS, Jarvis WD, Badamchian M, Goldstein AL, MacLeod RM.

Endocrinology. 1987 Dec;121(6):2035-43.

PMID:
2824178
50.

Cholinergic stimulation of inositol phosphate production in cultured anterior pituitary cells.

Canonico PL, Jarvis WD, Sortino MA, Scapagnini U, MacLeod RM.

Neuroendocrinology. 1987 Oct;46(4):306-11.

PMID:
2890115

Supplemental Content

Loading ...
Support Center